Form 3 - Initial statement of beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

Krispy Kreme (NASDAQ:DNUT)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Krispy Kreme Charts.

Krispy Kreme (NASDAQ:DNUT)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Krispy Kreme Charts.

Krispy Kreme Inc News

Form 3 - Initial statement of beneficial ownership of securities
Monday 3 March 2025 (9 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 3 March 2025 (9 hours ago) • Edgar (US Regulatory)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Friday 28 February 2025 (4 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 27 February 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 25 February 2025 (7 days ago) • Edgar (US Regulatory)

Krispy Kreme Reports Fourth Quarter and Full Year 2024 Financial Results
Tuesday 25 February 2025 (7 days ago) • Business Wire

KRISPY KREME® and Hulu Team Up for Lineup of New Movie Snacks Doughnuts
Monday 17 February 2025 (2 weeks ago) • Business Wire

Krispy Kreme Declares Quarterly Dividend
Thursday 13 February 2025 (3 weeks ago) • Business Wire

Krispy Kreme, Inc. to Announce Fourth Quarter and Full Year 2024 Results on February 25, 2025
Tuesday 11 February 2025 (3 weeks ago) • Business Wire

KRISPY KREME® is Making Hearts Flutter this Valentine’s Day with All-New Hearts in Bloom Collection
Monday 27 January 2025 (1 month ago) • Business Wire

Form 3 - Initial statement of beneficial ownership of securities
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 January 2025 (2 months ago) • Edgar (US Regulatory)

More Krispy Kreme Inc News Articles

Valiant Eagle (PK)

Anavex Life Sciences

Rennova Health (CE)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Global Developments (PK)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions